| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/30/2003 | CA2467536A1 The use of leptin in fertility |
| 05/29/2003 | US20030100607 Thiolalkyl benzoic acid derivatives |
| 05/29/2003 | US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands |
| 05/29/2003 | US20030100594 Carbonic anhydrase inhibitor |
| 05/29/2003 | US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 05/29/2003 | US20030100567 Tyrosine kinase inhibitors |
| 05/29/2003 | US20030100564 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 05/29/2003 | US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders |
| 05/29/2003 | US20030100556 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders |
| 05/29/2003 | US20030100543 Novel steroids containing a 14 beta ,15 beta - cyclopropane ring and a 17 alpha hydroxymethyl group; male contraceptives |
| 05/29/2003 | US20030100478 Articles of manufacture |
| 05/29/2003 | US20030099718 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 05/28/2003 | EP1313766A2 Coaster, a human coactivator of steroid receptors |
| 05/28/2003 | EP1313736A2 Condensed pyrazindione derivatives |
| 05/28/2003 | EP1313726A1 Quinoline derivatives having vegf inhibiting activity |
| 05/28/2003 | EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 05/28/2003 | EP1313707A1 Quinoline derivatives as anti-inflammation agents |
| 05/28/2003 | EP1313706A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 05/28/2003 | EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 05/28/2003 | EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds |
| 05/28/2003 | EP1313574A1 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| 05/28/2003 | EP1313511A2 Testosterone ester formulation for human use |
| 05/28/2003 | EP1313507A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 05/28/2003 | EP1313496A1 Use of a composition comprising an extract of pollen for the treatment of edema |
| 05/28/2003 | EP1313495A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
| 05/28/2003 | EP1313494A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 05/28/2003 | EP1313493A1 Use of a composition comprising an extract of pollen for the treatment of irritability |
| 05/28/2003 | EP1313492A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
| 05/28/2003 | EP1313491A1 Bioactive fraction of eurycoma longifolia |
| 05/28/2003 | EP1313489A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 05/28/2003 | EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 05/28/2003 | EP1313422A1 Non-hormonal vaginal contraceptive |
| 05/28/2003 | EP1163239B1 Modified amino-acid amides as cgrp antagonists |
| 05/28/2003 | EP1128810B1 Drug delivery device, especially for the delivery of androgens |
| 05/28/2003 | EP1011682B1 Hormonal contraceptive |
| 05/28/2003 | EP0988048A4 Ligand/lytic peptide compositions and methods of use |
| 05/28/2003 | EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 05/28/2003 | CN1420891A Pharmaceutical compound |
| 05/28/2003 | CN1420887A 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors |
| 05/28/2003 | CN1420886A (5R)-(methylamino)-5,6-dihydro-4H-imidazo ÒÇö4,5,1-ijÒÇòquinoline-2 (1H)-thione |
| 05/28/2003 | CN1420883A N-aryl-(homopiperazinyl) cyclohexyl amines as 5-HT transporters |
| 05/28/2003 | CN1420878A Compound with growth hormone releasing properties |
| 05/28/2003 | CN1420870A Modulators of dopamine neurotransmission |
| 05/28/2003 | CN1420869A Modulators of dopamine neurotransmission |
| 05/28/2003 | CN1420762A Devices for delivery of drugs having antiprogestinic properties |
| 05/28/2003 | CN1109683C 2-arylbenzo [b] thiophenes useful for treatment of estrogen deprivation syndrome |
| 05/28/2003 | CN1109675C Arylpyrimidine derivs. |
| 05/28/2003 | CN1109674C Imidazole deriv. and process for preparing same |
| 05/28/2003 | CN1109557C Cetroretix lyophilisate and process for preparation thereof |
| 05/27/2003 | US6569996 Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence |
| 05/27/2003 | US6569904 Via administration of toremifene for treatment or prevention of systemic/pulmonary hypertension, fibrosis, bronchial asthma, respiratory distress syndrome, myocardial infarction, thrombosis, congestive heart failure, and renal failure |
| 05/27/2003 | US6569896 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer |
| 05/27/2003 | US6569884 Conformationally rigid bicyclic and adamantane derivatives useful as α2-adrenergic blocking agents |
| 05/27/2003 | US6569872 Use of neurokinin receptor antagonists to treat androgen-dependent diseases |
| 05/27/2003 | US6569863 Bicyclic heteroamatic compounds useful as LH agonists |
| 05/27/2003 | US6569861 Melanin concentrating hormone receptor ligands |
| 05/27/2003 | US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 05/27/2003 | US6569468 Treatment of urogenital disorders, menstrual cramps |
| 05/27/2003 | US6569464 Antifertility agent comprises coelomic fluid extract which is obtained from an Indian earthworm, Pheretima posthuma, belonging to the phylum, Annelida |
| 05/27/2003 | US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides |
| 05/27/2003 | CA2231558C .gamma.-rar antagonist ligand or .alpha.-rar agonist ligand as an apoptosis inhibitor |
| 05/27/2003 | CA2066104C Benzazepine derivatives as vasopressin antagonists |
| 05/22/2003 | WO2003042390A1 Mammalian protein phosphatases |
| 05/22/2003 | WO2003042359A2 Histamine receptor h3 polynucleotides |
| 05/22/2003 | WO2003042357A2 Enzymes |
| 05/22/2003 | WO2003042216A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 05/22/2003 | WO2003042213A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 05/22/2003 | WO2003042208A1 Pyrazole derivatives as psychopharmaceuticals |
| 05/22/2003 | WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | WO2003042173A1 Nk1 antagonists |
| 05/22/2003 | WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | WO2003041732A2 Contraceptive vaccine compositions comprising a peptide or a plurality of peptides encoded by all or part of the exon 1 of a fsh receptor |
| 05/22/2003 | WO2003041720A1 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 05/22/2003 | WO2003041697A1 Method for treating autoimmune diseases |
| 05/22/2003 | WO2002096362A3 Method for treating fibrotic diseases or other indications vi |
| 05/22/2003 | WO2002089802A3 Use of neurokinin receptor antagonists to treat androgen-dependent diseases |
| 05/22/2003 | WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/22/2003 | US20030096992 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/22/2003 | US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 05/22/2003 | US20030096792 Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors |
| 05/22/2003 | US20030096758 Anticarcinogenic agents |
| 05/22/2003 | US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/22/2003 | US20030096746 Compounds and methods for inhibiting cancer metastasis |
| 05/22/2003 | US20030096387 Contacting the isomerase with a compound having the structure: A-X-A, where A is radical which mimics the steric and electronic properties of phosphoserin and/or phosphothreonine residue, X= spacer, R is cyclic, heterocylic or aryl ring |
| 05/22/2003 | US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
| 05/22/2003 | US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling |
| 05/22/2003 | US20030096012 Film-forming powder, compositions containing it, methods for their preparation and their uses |
| 05/22/2003 | US20030095960 Three human transferases, polynucleotides that identify and encode them, expression vectors, host cells, antibodies, agonists, and antagonists. |
| 05/22/2003 | CA2467347A1 Histamine receptor h3 polynucleotides |
| 05/22/2003 | CA2467081A1 Pyrazole derivatives as psychopharmaceuticals |
| 05/22/2003 | CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | CA2466519A1 Method for treating autoimmune diseases |
| 05/22/2003 | CA2466465A1 Nk1 antagonists |
| 05/22/2003 | CA2465893A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 05/22/2003 | CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | CA2460959A1 Enzymes |
| 05/21/2003 | EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 05/21/2003 | EP1312371A1 Animal papilla disinfectants and method of improving microbial environment |
| 05/21/2003 | EP1312365A1 Pteridinones for the treatment of erectile dysfunctions |
| 05/21/2003 | EP1312363A1 Methods of treatment and kits comprising a growth hormone secretagogue |